Tuesday, June 14, 2022

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model.

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model.

visit: https://infectious.pencis.com/

Online Nomination: https://x-i.me/ian1

Contact Us: infectious@pencis.com


#antiviral #conferences #infectiousdisease #virology #award #virusresearch #immunology #bacteriology #pathology #infectiousdiseaseresearch #tuberculosisconference

-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Biogenic Copper-Based Nanoparticles: Emerging Antimicrobial Agents Against Pathogenic Microorganisms | Nanomedicine & Infection Control #researchawards

Introduction Biogenic copper-based nanoparticles (CuNPs) have emerged as promising antimicrobial agents due to their potent activity and en...